Autologous stem cell transplantation in multiple myeloma: The effect of CD 34+ cell selection.

被引：0
|
作者：
Patriarca, F
Fanin, R
Damiani, D
Silvestri, F
Geromin, A
Sperotto, A
Cerno, M
Grimaz, S
Stocchi, R
Baccarani, M
机构：
[1] Udine Univ Hosp, Div Haematol, I-33100 Udine, Italy
[2] Udine Univ Hosp, Dept Bone Marrow Transplantat, I-33100 Udine, Italy
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4593
引用
收藏
页码：370B / 370B
页数：1
相关论文
共 50 条
  • [21] Autologous and allogeneic stem cell transplantation in multiple myeloma
    Goldschmidt, H
    Egerer, G
    Ho, AD
    BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S25 - S26
  • [22] CD 34+ selected blood stem cell transplantation after priming with filgrastim alone at 10 mu g/kg in multiple myeloma
    Feremans, WW
    Ravoet, C
    Lemoine, F
    Delville, JP
    Pradier, O
    Bastin, G
    Kentos, A
    Neve, P
    Delannoy, A
    Dupont, E
    Lambermont, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 313 - 313
  • [23] Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation
    Pasvolsky, Oren
    Marcoux, Curtis
    Milton, Denai R.
    Pal, Babar
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Lee, Jaehyun
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Aljawai, Yosra
    Kebriaei, Partow
    Becnel, Melody R.
    Lee, Hans C.
    Patel, Krina K.
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [24] Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+ selected donor cells without immunosuppression
    Polona Novak
    Evgeny Klyuchnikov
    Ute-Marie von Pein
    Martina Güllstorf
    Maximilian Christopeit
    Francis Ayuk
    Maria Geffken
    Christine Wolschke
    Nicolaus Kröger
    Bone Marrow Transplantation, 2020, 55 : 1817 - 1820
  • [25] Effect of CD34+ cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
    Klaus, Jens
    Herrmann, Doris
    Breitkreutz, Iris
    Hegenbart, Ute
    Mazitschek, Uta
    Egerer, Gerlinde
    Cremer, Friedrich W.
    Lowenthal, Ray M.
    Huesing, Johannes
    Fruehauf, Stefan
    Moehler, Thomas
    ho, Antny D. Ho
    Goldschmidt, Hartmut
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (01) : 21 - 28
  • [26] Autologous stem cell transplantation in multiple myeloma: A single centre experience in 34 cases.
    Patriarca, F
    Fanin, R
    Infanti, L
    Geromin, A
    Sperotto, A
    Cerno, M
    Candoni, A
    Savignano, C
    Rinaldi, C
    Silvestri, F
    Damiani, D
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S199 - S199
  • [27] Autologous Stem Cell Transplantation and Multiple Myeloma Cancer Stem Cells
    Matsui, William
    Borrello, Ivan
    Mitsiades, Constantine
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) : S27 - S32
  • [28] Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
    Elisa Roldan
    Miguel Angel Perales
    Pere Barba
    Clinical Hematology International, 2019, 1 (3) : 154 - 160
  • [29] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis
    MK Gandhi
    HK Jestice
    MA Scott
    DM Bloxham
    G Bass
    JIO Craig
    RE Marcus
    Bone Marrow Transplantation, 1999, 24 : 369 - 375
  • [30] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma:: a case controlled analysis
    Gandhi, MK
    Jestice, HK
    Scott, MA
    Bloxham, DM
    Bass, G
    Craig, JIO
    Marcus, RE
    BONE MARROW TRANSPLANTATION, 1999, 24 (04) : 369 - 375
12345